iOnctura starts randomised phase 1/2 trial in lung cancer treatment
8th May 2025 Uncategorised 0
Study explores whether PI3Kδ targeting could combat resistance

More: iOnctura starts randomised phase 1/2 trial in lung cancer treatment
Source: News
Study explores whether PI3Kδ targeting could combat resistance

More: iOnctura starts randomised phase 1/2 trial in lung cancer treatment
Source: News
© 1994 - 2026 B.M. Pharmaceuticals